Epi 321: GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are reshaping how we treat obesity — but there’s so much confusion and stigma. That’s why we sat down with leading obesity specialist Dr. Spencer Nadolsky for an honest, empowering conversation.

We break down how GLP-1s actually work, why food noise is real, and what people aren’t being told about compounded semaglutide, weight regain after bariatric surgery, and long-term success.

If you’ve felt frustrated, misunderstood, or stuck — this episode is for you. Whether you're post-op, on medication, or considering your options, this episode brings science, support, and real talk together.

💬 Topics we cover:

Semaglutide vs Tirzepatide: What’s the difference?

The truth about compounded medications

Why GLP-1s might still be needed after bariatric surgery

How to talk to your doctor about options

Breaking the stigma: Obesity is not a personal failure

🎧 Listen. Learn. Heal. You’re not alone.

📲 Follow & Subscribe for More
🌐 Website: oursleevedlifepodcast.com
📸 Instagram: @oursleevedlifepodcast
🎧 Listen on Spotify | Apple | YouTube

#GLP1 #WeightLossMedication #OurSleevedLife #Semaglutide #Tirzepatide #ObesityIsADisease #BariatricSurgery #FoodNoise #WeightLossJourney #DrSpencerNadolsky #Mounjaro #Wegovy #Ozempic